Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

STEP 4

Novo Nordisk · Phase 3 · Completed · Enrollment 902

NCT03548987

EudraCT 2017-003473-34

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Semaglutiden/rn/rn/rn/rn/r
Placebon/rn/rn/rn/rn/r
Semaglutide 2.4 mg, in trialn/rn/rn/rn/rn/r
Placebo, in trial13 participants8 participants19 participantsn/r1

A count stays a count. This page does not turn a count into a percent.